Peking University Third Hospital
Beijing, Beijing Municipality, 010, China
NCT Number: NCT04955522
In this study, we retrospectively analyzed the imaging data of spinal tumors to find out more imaging features of spinal tumors, in order to provide more accurate reference for the diagnosis of spinal tumors.
Looking for future studies?
Notify MeAll sexes
Observational
Beijing, Beijing Municipality, 010, China
Bone tumors account for 1-2% of total body tumors, and spinal tumors only account for 6.5% of total body tumors. Because of the low incidence rate, the number of patients and the attention in this field are far lower than other tumors, so far, all the researches on spinal tumors are relatively lacking. Because the diagnosis of bone tumor needs the combination of clinical, imaging and pathological to make a more accurate diagnosis, so the imaging diagnosis of spinal tumor is very important. In this study, through retrospective analysis of a variety of imaging data of patients with spinal tumor, measurement and recording of spinal tumor image related parameters, and statistical analysis, in order to find out more imaging characteristics of patients with spinal tumor, more accurate diagnosis of lesions, and provide more help for clinical decision-making.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Differential diagnosis of spinal myeloma and metastases by radiomics
Time frame: 2020.12.1-2020.12.25
1409 radiomics features can be extracted from the images. Objective to search for the radiomics index which is helpful to the diagnosis of tumor.
Peking University Third Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06376682
Bone Diseases, Bone Metastases
Lyon, France
View Trial DetailsNCT05772312
Bone Diseases, Bone Neoplasms
Bologna, Italy
View Trial DetailsNCT04755140
Bone Diseases, Bone Neoplasms
Rochester, Minnesota, United States
View Trial DetailsNCT04104750
Bone Diseases, Bone Neoplasms
Bologna, BO, Italy
View Trial Details